Jazz Pharmaceuticals publishes cancer trial results in medical journal

May 27, 2026 5:00 PM

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced that The New England Journal of Medicine published results from its Phase 3 HERIZON-GEA-01 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found